Cancer Research Technology has an impressive range of oncology-focused projects under development and potentially available for licensing. All are involved in the fight against cancer and include novel chemotherapeutic and biological agents, diagnostic methodologies and enabling technologies. These projects have arisen from diverse areas of cancer research including angiogenesis, signal transduction, cancer immunology and immunotherapy, cell cycle control, as well as the potentiation of existing therapies, for instance by inhibiting DNA repair. The projects range from new targets to therapies in pre-clinical development to those in Phase I/II clinical studies.

CRT is currently managing over 200 projects, with many of these available for licensing. Other projects are being developed through further research conducted either by our own CRT Development Laboratories or by the originating academic groups in collaboration with CRT.

Relevant licensing opportunities can be identified using the navigation bar on the left or through the search function below.

To download CRT's current Therapeutic, Diagnostic and Platform Technology Licensing Portfolio click here.

Please register if you would like to receive updates of CRT's Licensing Portfolio.